10-K: Catheter Precision Outlines Capital Structure and Stock Details in 10-K Filing

Catheter Precision's 10-K filing details its capital stock, including common and preferred shares, warrants, and anti-takeover provisions.

Summary

• Catheter Precision's 10-K filing outlines the company's capital structure, including 300 million authorized common shares and 10 million preferred shares, each with a par value of $0.0001.
• As of March 4, 2024, there were 7,573,403 common shares issued and outstanding, held by 112 record holders as of March 12, 2024.
• The company has two classes of preferred stock: Series A, with 4,578 shares outstanding as of December 31, 2023, each convertible into approximately 625 common shares, and Series X, with 12,656 shares outstanding, each convertible into 1,000 common shares.
• Series A preferred stock has limited conversion rights based on beneficial ownership limitations, while Series X preferred stock conversion is restricted until a new exchange listing or delisting from NYSE American and after July 9, 2024.
• The document lists various outstanding warrants to purchase common stock, totaling 11,042,137 shares, with different exercise prices and expiration dates, all subject to beneficial ownership limitations.
• The Series B warrants are callable by the company under certain conditions, including a stock price exceeding $75.00 for 20 consecutive trading days and average daily trading volume exceeding $500,000.
• The filing also details anti-takeover provisions, including a classified board, limits on stockholder actions, and a Delaware anti-takeover statute, which could deter hostile takeovers.

Sentiment

Score: 5

Explanation: The document is neutral in tone, providing factual information about the company's capital structure. It does not express any positive or negative sentiment.

Positives

• The document provides a detailed overview of the company's capital structure.
• The document clearly outlines the terms and conditions of the various classes of stock and warrants.
• The document provides transparency regarding the company's anti-takeover provisions.

Negatives

• The document highlights restrictions on the conversion of preferred stock, which could limit shareholder flexibility.
• The document outlines anti-takeover provisions, which could deter potential acquirers.
• The document notes that the issuance of additional preferred stock could further restrict dividends on common stock and dilute voting power.

Risks

• The issuance of additional preferred stock could further restrict dividends on the common stock, dilute the voting power of the common stock, impair the liquidation rights of the common stock or delay, deter or prevent a change in control.
• The anti-takeover provisions could discourage takeover bids and inhibit temporary fluctuations in the market price of the common stock.
• The absence of cumulative voting makes it more difficult for a minority stockholder to gain a seat on the board of directors.

Future Outlook

The document does not contain specific forward-looking statements about the company's future financial performance, but it does outline the terms of the company's capital structure and potential future actions related to stock issuance and anti-takeover measures.

Industry Context

This document is a standard SEC filing detailing the capital structure of a publicly traded company. It is common for companies to include anti-takeover provisions to protect themselves from hostile acquisitions.

Comparison to Industry Standards

• The capital structure described is typical for a publicly traded company, with a mix of common and preferred stock, as well as warrants.
• The anti-takeover provisions are also common among publicly traded companies, particularly those that may be vulnerable to hostile takeovers.
• The specific terms of the preferred stock and warrants, such as conversion ratios and exercise prices, are specific to Catheter Precision and its financing history.

Stakeholder Impact

• Shareholders may be impacted by the anti-takeover provisions, which could limit their ability to influence the company's direction.
• Shareholders may be impacted by the potential dilution of their ownership due to the issuance of additional preferred stock and warrants.
• Potential acquirers may be deterred by the anti-takeover provisions.

Key Dates

Keywords

capital stock, common stock, preferred stock, warrants, anti-takeover, Delaware law, NYSE American, voting rights, conversion rights, dividends